Johnson & Johnson Single Injection 66% Effective Against Moderate and Severe Disease – The Washington Post

by



[ad_1]

  1. Johnson & Johnson single injection vaccine 66% effective against moderate and severe diseaseThe Washington Post
  2. Johnson & Johnson’s vaccine offers strong protection but fuels concern over variantsThe New York Times
  3. Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against serious illness, company saysCNN
  4. Indiana Coronavirus Updates: Johnson & Johnson 1-Dose Vaccine Prevents COVID-19, But Less Than OthersWTHR
  5. J&J says its one-shot Covid vaccine is 72% effective in USCNBC Television
  6. View full coverage on Google News

[ad_2]

Source link